Otros idiomas Recursion Pharmaceuticals, Inc.

Acciones

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
8,12 ^USD	+3,57 %		+10,48 %	-17,65 %

18/04	Un iniciado de Recursion Pharmaceuticals vendió acciones por valor de 367.007 dólares, según un reciente registro de la SEC	MT
16/04	Recursion nombra a Najat Khan directora de I+D y directora comercial	CI

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	18/04
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion Publishes Annual Environmental, Social and Governance Report	26/03
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23/03
50 titoli per investire in AI, salute, mobilità ed energia	22/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
50 valeurs pour investir dans l'IA, la Santé, la Mobilité et l'Energie	22/03
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15/03
Recursion Pharmaceuticals to Open London Office	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03

No hay resultados para esta búsqueda